Novartis Pharma AG
Get the Full Report for Novartis Pharma AG
See every shipment, partner, and contact.
Contact Novartis Pharma AG
Reach the right decision-maker by email or phone.
Grab Limited-Time Offer
7-day free trial. No credit card needed.
| HS Code | Description | USD Value | Shipments | Share |
|---|---|---|---|---|
| 29339990 | HETEROCYCLIC COMPOUNDS WITH NITROGEN HETEROATOM(S) ONLY | $132.07M | 101 | 20.49% |
| 29333990 | HETEROCYCLIC COMPOUNDS WITH NITROGEN HETEROATOM(S) ONLY | $5.14M | 17 | 3.45% |
| 29224990 | OXYGEN-FUNCTION AMINO-COMPOUNDS | $4.60M | 25 | 5.07% |
| 29252990 | CARBOXYIMIDE-FUNCTION COMPOUNDS (INCLUDING SACCHARIN AND ITS SALTS) AND IMINE-FUNCTION COMPOUNDS | $2.90M | 21 | 4.26% |
| 29242990 | CARBOXYAMIDE-FUNCTION COMPOUNDS; AMIDE-FUNCTION COMPOUNDS OF CARBONIC ACID | $1.72M | 6 | 1.22% |
| HS Code | Description | USD Value | Shipments | Share |
|---|---|---|---|---|
| 30049099 | MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | $84.56M | 481 | 72.99% |
| 30021500 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $23.04M | 42 | 6.37% |
| 30042019 | MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | $10.60M | 39 | 5.92% |
| 30049049 | MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | $6.90M | 34 | 5.16% |
| 30042099 | MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | $4.08M | 24 | 3.64% |
| Country | USD Value | Shipments | Share |
|---|---|---|---|
| Switzerland | $146.42M | 458 | 92.9% |
| Netherlands | $2.90M | 21 | 4.26% |
| Romania | $1.68M | 12 | 2.43% |
| United States | $140.0K | 2 | 0.41% |
| Country | USD Value | Shipments | Share |
|---|---|---|---|
| Switzerland | $61.06M | 115 | 17.45% |
| Italy | $27.20M | 103 | 15.63% |
| Turkey | $11.44M | 210 | 31.87% |
| Germany | $7.66M | 74 | 11.23% |
| Singapore | $7.60M | 7 | 1.06% |
| Port | USD Value | Shipments | Share |
|---|---|---|---|
| Hyderabad Air Cargo | $8.41M | 311 | 63.08% |
| Divis Laboratories Ltd (sez) | $132.07M | 100 | 20.28% |
| Nhava Sheva Sea | $3.61M | 27 | 5.48% |
| Hetero Infrastructure Sez Ltd (sez) | $4.86M | 18 | 3.65% |
| Bombay Air Cargo | $1.82M | 18 | 3.65% |
| Biocon Special Economic Zone (sez) | $360.0K | 11 | 2.23% |
| Port | USD Value | Shipments | Share |
|---|---|---|---|
| Bombay Air Cargo | $129.34M | 619 | 93.93% |
| Nhava Sheva Sea | $2.32M | 24 | 3.64% |
| Zydus Infrastructure Pvt. Ltd. (sez) | $0 | 8 | 1.21% |
| Hyderabad Air Cargo | $620.0K | 5 | 0.76% |
| Delhi Air Cargo | $350.0K | 2 | 0.3% |
- 92.9% of exports go to Switzerland. This is their biggest market.
- Their main product is heterocyclic compounds with nitrogen heteroatom(s) only… (
HS 29339990). It is 20.49% of all trade.
Novartis Pharma AG is an importer / exporter from Switzerland. We have 1,433 shipment records for them. They have 910 imports from 1 supplier, and 523 exports to 1 buyer.
Most of their exports go to Switzerland. This is their main market.
This page shows trade records for Novartis Pharma AG. The data comes from public customs and port records. to see all shipments, decision-maker contacts, and trade alerts.
How many shipments does Novartis Pharma AG have on record?
Novartis Pharma AG has 910 import shipments and 523 export shipments on record based on public customs filings indexed by ShipScout.
Where is Novartis Pharma AG based?
Customs records indicate Novartis Pharma AG primarily operates from Switzerland.
Who are Novartis Pharma AG's top buyers?
Novartis Pharma AG's top buyers include CJ Cheil Jedang Corporation, Bayer AG, Yusen Logistics C O Teva Pharma. The full buyer list is available on ShipScout.
What products does Novartis Pharma AG trade?
Novartis Pharma AG's top exported HS codes include HS 29339990, HS 29333990, HS 29224990.
How can I get full shipment history for Novartis Pharma AG?
Request access to view the complete shipment history, contact intelligence and trade partners for Novartis Pharma AG on ShipScout.
Browse by Product Code
Get the Full Report for Novartis Pharma AG
See every shipment, partner, and contact.
Contact Novartis Pharma AG
Reach the right decision-maker by email or phone.
Grab Limited-Time Offer
7-day free trial. No credit card needed.